Cite
HARVARD Citation
Peviani, M. et al. (2023). An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model. EMBO molecular medicine. 15 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Peviani, M. et al. (2023). An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model. EMBO molecular medicine. 15 (4), p. n/a. [Online].